ANEB

PINK Anebulo Pharmaceuticals, Inc.
Oct 7, 2026 · 7:32 PM ET LAST TRADE Market Closed

$0.3200 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3200, and at the day’s high of $0.3200

YTD change
-68.32%
vs 20-day SMA
-3.05%
vs 200-day SMA
-52.03%

Price ranges

Previous day
$0.3200 $0.3200
open $0.3200 close $0.3200
+$0.0000 (+0.00%)
Today
$0.3200 $0.3200
open $0.3200 now $0.3200
+$0.0000 (+0.00%)
Past week
$0.3200 $0.3200
from $0.3200 now $0.3200
+$0.0000 (+0.00%)
Past month
$0.0110 $0.3900
from $0.3586 now $0.3200
-$0.0386 (-10.76%)
This year
$0.0004 $1.2300
from $1.0100 now $0.3200
-$0.6900 (-68.32%)

Price & Performance

-0.33 (-50.91%) / 6M

$-0.0517$0.2002$0.4521$0.7040Apr 7Jul 1Oct 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 96.6% away from all-time highs of $9.3300
  • ANEB is down 68% since the beginning of the year
  • ANEB is down 86% over the past 12 months
  • ANEB is down 11% over the past 1 month
  • 2% of all ANEB investors are betting against ANEB

ANEB reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -86.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0487
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $4.1M
Beta -2.73

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$9.0M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $13.0M

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $738.72 +1.69%
IQV IQVIA Holdings Inc $259.98 -2.30%
CRL Charles River Laboratories International, Inc. $304.96 -1.87%
ICLR ICON Plc $161.69 -3.94%
IT Gartner, Inc. $184.92 -1.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.